HK Stock MarketDetailed Quotes
02616 CSTONE PHARMA-B
- 1.970
- -0.030-1.50%
Market Closed Nov 26 16:08 CST
2.53BMarket Cap-16280P/E (TTM)
2.010High1.940Low1.17MVolume1.970Open2.000Pre Close2.29MTurnover0.09%Turnover RatioLossP/E (Static)1.28BShares2.95052wk High4.94P/B2.53BFloat Cap0.80052wk Low--Dividend TTM1.28BShs Float19.120Historical High--Dividend LFY3.50%Amplitude0.800Historical Low1.966Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
CSTONE PHARMA-B Key Stats
EPS
According to the latest financial report of CSTONE PHARMA-B, the latest earnings per share (TTM) for the company is 0.01. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out CSTONE PHARMA-B's latest financial report to see how much their book value per share (BVPS) is currently at 0.40.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of CSTONE PHARMA-B shows that the company's current ratio is 1.71, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of CSTONE PHARMA-B, the quick ratio is 1.45, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of CSTONE PHARMA-B? The latest ROE figure is 3.38%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of CSTONE PHARMA-B, the total asset return on investment (ROA) is 0.98%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check CSTONE PHARMA-B's latest financial report to see how their gross margin is doing - currently at 67.68%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of CSTONE PHARMA-B, the net profit margin is 6.18%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data